David Stanton
Stock Analyst at Jefferies
(4.21)
# 1,468
Out of 4,520 analysts
211
Total ratings
46.1%
Success rate
13.2%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: PME Pro Medicus Limited | Downgraded: Hold | $192.60 | $187.11 | +2.93% | 2 | Jul 13, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $22.55 → $22.60 | $21.88 | +3.29% | 20 | Jun 21, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Buy | $0.90 → $0.80 | $0.69 | +15.94% | 10 | Jun 12, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $195.00 → $108.00 | $123.32 | -12.42% | 23 | May 29, 2026 | |
| ASX: HLS Healius Limited | Maintained: Hold | $0.81 → $0.45 | $0.38 | +20.00% | 16 | May 13, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Buy | $3.05 → $3.30 | $2.93 | +12.63% | 17 | May 5, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $40.00 → $39.20 | $9.92 | +295.16% | 10 | Apr 24, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $285.00 → $137.00 | $119.48 | +14.66% | 18 | Apr 23, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $24.30 → $27.40 | $14.91 | +83.77% | 22 | Apr 15, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $3.30 → $2.80 | $2.44 | +14.75% | 15 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.10 → $0.04 | $0.05 | -20.00% | 8 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.60 → $27.00 | $16.97 | +59.10% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5.00 | $2.32 | +115.52% | 11 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38.65 → $34.50 | $43.12 | -19.99% | 11 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 → $3.50 | $2.10 | +66.67% | 8 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.28 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.17 | n/a | 3 | Apr 8, 2021 |
Pro Medicus Limited
Jul 13, 2026
Downgraded: Hold
Price Target: $192.60
Current: $187.11
Upside: +2.93%
Sonic Healthcare Limited
Jun 21, 2026
Maintained: Hold
Price Target: $22.55 → $22.60
Current: $21.88
Upside: +3.29%
Monash IVF Group Limited
Jun 12, 2026
Maintained: Buy
Price Target: $0.90 → $0.80
Current: $0.69
Upside: +15.94%
CSL Limited
May 29, 2026
Downgraded: Hold
Price Target: $195.00 → $108.00
Current: $123.32
Upside: -12.42%
Healius Limited
May 13, 2026
Maintained: Hold
Price Target: $0.81 → $0.45
Current: $0.38
Upside: +20.00%
Sigma Healthcare Limited
May 5, 2026
Maintained: Buy
Price Target: $3.05 → $3.30
Current: $2.93
Upside: +12.63%
Clinuvel Pharmaceuticals Limited
Apr 24, 2026
Maintained: Buy
Price Target: $40.00 → $39.20
Current: $9.92
Upside: +295.16%
Cochlear Limited
Apr 23, 2026
Maintained: Buy
Price Target: $285.00 → $137.00
Current: $119.48
Upside: +14.66%
Telix Pharmaceuticals Limited
Apr 15, 2026
Maintained: Buy
Price Target: $24.30 → $27.40
Current: $14.91
Upside: +83.77%
Mesoblast Limited
Apr 9, 2026
Maintained: Buy
Price Target: $3.30 → $2.80
Current: $2.44
Upside: +14.75%
Mar 13, 2026
Downgraded: Hold
Price Target: $2.10 → $0.04
Current: $0.05
Upside: -20.00%
Feb 5, 2026
Maintained: Buy
Price Target: $28.60 → $27.00
Current: $16.97
Upside: +59.10%
Dec 16, 2025
Upgraded: Buy
Price Target: $5.00
Current: $2.32
Upside: +115.52%
Aug 28, 2025
Maintained: Hold
Price Target: $38.65 → $34.50
Current: $43.12
Upside: -19.99%
Aug 26, 2025
Maintained: Buy
Price Target: $3.30 → $3.50
Current: $2.10
Upside: +66.67%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $17.28
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $15.17
Upside: n/a